Arthroplasty, Replacement, Hip
This graph shows the total number of publications written about "Arthroplasty, Replacement, Hip" by people in the URMC Research Network by year, and whether "Arthroplasty, Replacement, Hip" was a major or minor topic of these publication.
Below are the most recent publications written about "Arthroplasty, Replacement, Hip" by people in Profiles.
-
Kaatz S, Spyropoulos AC. Venous thromboembolism prophylaxis after hospital discharge: transition to preventive care. Hosp Pract (Minneap). 2011 Aug; 39(3):7-15.
-
Cram P, Lu X, Kaboli PJ, Vaughan-Sarrazin MS, Cai X, Wolf BR, Li Y. Clinical characteristics and outcomes of Medicare patients undergoing total hip arthroplasty, 1991-2008. JAMA. 2011 Apr 20; 305(15):1560-7.
-
Friedman RJ, Dahl OE, Rosencher N, Caprini JA, Kurth AA, Francis CW, Clemens A, Hantel S, Schnee JM, Eriksson BI. Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: a pooled analysis of three trials. Thromb Res. 2010 Sep; 126(3):175-82.
-
Chelly JE, Szczodry DM, Neumann KJ. International normalized ratio and prothrombin time values before the removal of a lumbar plexus catheter in patients receiving warfarin after total hip replacement. Br J Anaesth. 2008 Aug; 101(2):250-4.
-
Mandelin J, Liljeström M, Li TF, Ainola M, Hukkanen M, Salo J, Santavirta S, Konttinen YT. Pseudosynovial fluid from loosened total hip prosthesis induces osteoclast formation. J Biomed Mater Res B Appl Biomater. 2005 Jul; 74(1):582-8.
-
Mandelin J, Li TF, Hukkanen M, Liljeström M, Salo J, Santavirta S, Konttinen YT. Interface tissue fibroblasts from loose total hip replacement prosthesis produce receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, and cathepsin K. J Rheumatol. 2005 Apr; 32(4):713-20.
-
Schwarz EM, O'Keefe RJ, Looney RJ. Bone implant interface, osteolysis and potential therapies. J Musculoskelet Neuronal Interact. 2004 Dec; 4(4):390-2.
-
Claus AM, Totterman SM, Sychterz CJ, Tamez-Peña JG, Looney RJ, Engh CA. Computed tomography to assess pelvic lysis after total hip replacement. Clin Orthop Relat Res. 2004 May; (422):167-74.
-
Motobe T, Hashiguchi T, Uchimura T, Yamakuchi M, Taniguchi N, Komiya S, Maruyama I. Endogenous cannabinoids are candidates for lipid mediators of bone cement implantation syndrome. Shock. 2004 Jan; 21(1):8-12.
-
Schwarz EM, Campbell D, Totterman S, Boyd A, O'Keefe RJ, Looney RJ. Use of volumetric computerized tomography as a primary outcome measure to evaluate drug efficacy in the prevention of peri-prosthetic osteolysis: a 1-year clinical pilot of etanercept vs. placebo. J Orthop Res. 2003 Nov; 21(6):1049-55.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
|
